Skip to main content
Log in

The pharmacokinetics ofα-human atrial natriuretic polypeptide in healthy subjects

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

We have analysed the pharmacokinetics ofα-human atrial natriuretic polypeptide (α-hANP) in healthy subjects, using a two-compartment open model following bolus intravenous injection. The plasma half-times for the fast and slow components were 1.7±0.07 min and 13.3±1.69 min respectively. V1 (the volume of the central compartment), Vz (volume of distribution) and Vss (volume of distribution at steady-state) were 5370±855 ml (89.5±14.3 ml·kg−1), 32000±4620 ml (533±77.0 ml·kg−1), and 11900±1530 ml (198±25.5 ml·kg−1) respectively. The mean plasma clearance was 1520±121 ml·min−1 (25.4±2.0 ml·min−1·kg−1.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 28: 89–94

    Google Scholar 

  2. Kangawa K, Matsuo H (1984) Purification and complete amino acid sequence ofα-human atrial natriuretic polypeptide. Biochem Biophys Res Commun 118: 131–139

    Google Scholar 

  3. de Bold AJ (1985) Atrial natriuretic factor: A hormone produced by the heart. Science 230: 767–770

    Google Scholar 

  4. Cantin M, Genest J (1985) The heart and the atrial natriuretic factor. Endocr Rev 6: 107–127

    Google Scholar 

  5. Needleman P, Adams SP, Cole BR, Currie MG, Geller DM, Michener ML, Saper CB, Schwartz D, Standaert DG (1985) Atriopeptins as cardiac hormone. Hypertension 7: 469–482

    Google Scholar 

  6. Nakao K, Sugawara A, Morii N, Sakamoto M, Suda M, Soneda J, Ban T, Kihara M, Yamori Y, Shimokura M, Kiso Y, Imura H (1984) Radioimmunoassay forα-human and rat atrial natriuretic polypeptide. Biochem Biophys Res Commun 124: 815–821

    Google Scholar 

  7. Sugawara A, Nakao K, Morii N, Sakamoto M, Suda M, Shimokura M, Kiso Y, Kihara M, Yamori Y, Nishimura K, Soneda J, Ban T, Imura H (1985)α-Human atrial natriuretic polypeptide is released from the heart and circulates in the body. Biochem Biophys Res Commun 129: 439–446

    Google Scholar 

  8. Sugawara A, Nakao K, Morii N, Sakamoto M, Horii K, Shimokura M, Kiso Y, Nishimura K, Ban T, Kihara M, Yamori Y, Kangawa K, Matsuo H, Imura H (1986) Significance ofα-human atrial natriuretic polypeptide as a hormone in man. Hypertension 8 [Suppl I]: 151–155

    Google Scholar 

  9. Morii N, Nakao K, Sugawara A, Sakamoto M, Suda M, Shimokura M, Kiso Y, Kihara M, Yamori Y, Imura H (1985) Occurrence of atrial natriuretic polypeptide in brain. Biochem Biophys Res Commun 127: 413–419

    Google Scholar 

  10. Wagner JG (1975) The two compartment open model. In: Wagner JG (ed) Fundamentals of clinical pharmacokinetics. The Hamilton Press, Hamilton, Illinois, pp 82–83

    Google Scholar 

  11. Yamaoka K, Tanigawara Y, Nakagawa T, Uno T (1981) A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharm Dyn 4: 879–885

    Google Scholar 

  12. Sakamoto M, Nakao K, Kihara M, Morii N, Sugawara A, Suda M, Shimokura M, Kiso Y, Yamori Y, Imura H (1985) Existence of atrial natriuretic polypeptide in kidney. Biochem Biophys Res Commun 128: 1281–1287

    Google Scholar 

  13. Richards AM, Nicholls MG, Ikram H, Webster MW, Yandle TG, Espiner EA (1985) Renal, hemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet 1: 545–548

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakao, K., Sugawara, A., Morii, N. et al. The pharmacokinetics ofα-human atrial natriuretic polypeptide in healthy subjects. Eur J Clin Pharmacol 31, 101–103 (1986). https://doi.org/10.1007/BF00870995

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00870995

Key words

Navigation